Elekta AB (publ) (EKTA-B.ST)
SEK 61.7
(2.32%)
SEK 61.7
(2.32%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.8 Billion SEK | -25.1% |
| 2022 | 6.41 Billion SEK | 29.92% |
| 2021 | 4.94 Billion SEK | 26.76% |
| 2020 | 3.89 Billion SEK | -52.15% |
| 2019 | 8.14 Billion SEK | 128.89% |
| 2018 | 3.55 Billion SEK | -18.56% |
| 2017 | 4.36 Billion SEK | -17.13% |
| 2016 | 5.27 Billion SEK | 72.01% |
| 2015 | 3.06 Billion SEK | -38.18% |
| 2014 | 4.95 Billion SEK | 13.69% |
| 2013 | 4.36 Billion SEK | 0.48% |
| 2012 | 4.34 Billion SEK | -1.74% |
| 2011 | 4.41 Billion SEK | 464.83% |
| 2010 | 782 Million SEK | -16.54% |
| 2009 | 937 Million SEK | -37.86% |
| 2008 | 1.5 Billion SEK | 6.5% |
| 2007 | 1.41 Billion SEK | 68.57% |
| 2006 | 840 Million SEK | -19.92% |
| 2005 | 1.04 Billion SEK | 32.95% |
| 2004 | 789 Million SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| 2001 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 4.81 Billion SEK | 0.08% |
| 2023 FY | 4.8 Billion SEK | -25.1% |
| 2023 Q3 | 5.73 Billion SEK | -13.19% |
| 2023 Q4 | 4.8 Billion SEK | -16.23% |
| 2023 Q1 | 6.51 Billion SEK | 1.5% |
| 2023 Q2 | 6.61 Billion SEK | 1.47% |
| 2022 Q2 | 4.92 Billion SEK | 0.06% |
| 2022 Q3 | 4.88 Billion SEK | -0.83% |
| 2022 FY | 6.41 Billion SEK | 29.92% |
| 2022 Q1 | 4.91 Billion SEK | -0.43% |
| 2022 Q4 | 6.41 Billion SEK | 31.49% |
| 2021 Q3 | 5.5 Billion SEK | 41.11% |
| 2021 Q4 | 4.94 Billion SEK | -10.21% |
| 2021 FY | 4.94 Billion SEK | 26.76% |
| 2021 Q2 | 3.89 Billion SEK | -0.03% |
| 2021 Q1 | 3.9 Billion SEK | 0.08% |
| 2020 Q4 | 3.89 Billion SEK | -32.8% |
| 2020 Q2 | 5.89 Billion SEK | -25.04% |
| 2020 FY | 3.89 Billion SEK | -52.15% |
| 2020 Q1 | 7.85 Billion SEK | -3.5% |
| 2020 Q3 | 5.79 Billion SEK | -1.56% |
| 2019 Q1 | 4.55 Billion SEK | 27.91% |
| 2019 FY | 8.14 Billion SEK | 128.89% |
| 2019 Q2 | 4.17 Billion SEK | -8.26% |
| 2019 Q3 | 3.66 Billion SEK | -12.31% |
| 2019 Q4 | 8.14 Billion SEK | 122.45% |
| 2018 Q4 | 3.55 Billion SEK | -20.28% |
| 2018 FY | 3.55 Billion SEK | -18.56% |
| 2018 Q3 | 4.46 Billion SEK | 0.93% |
| 2018 Q2 | 4.42 Billion SEK | 1.87% |
| 2018 Q1 | 4.34 Billion SEK | -0.64% |
| 2017 Q1 | 4.65 Billion SEK | -11.8% |
| 2017 Q4 | 4.36 Billion SEK | 4.52% |
| 2017 FY | 4.36 Billion SEK | -17.13% |
| 2017 Q3 | 4.18 Billion SEK | -11.55% |
| 2017 Q2 | 4.72 Billion SEK | 1.63% |
| 2016 Q4 | 5.27 Billion SEK | 63.02% |
| 2016 Q2 | 3.29 Billion SEK | 2.78% |
| 2016 Q3 | 3.23 Billion SEK | -1.7% |
| 2016 FY | 5.27 Billion SEK | 72.01% |
| 2016 Q1 | 3.2 Billion SEK | 4.44% |
| 2015 Q1 | 5.04 Billion SEK | 1.8% |
| 2015 Q3 | 5.03 Billion SEK | 0.14% |
| 2015 FY | 3.06 Billion SEK | -38.18% |
| 2015 Q2 | 5.02 Billion SEK | -0.46% |
| 2015 Q4 | 3.06 Billion SEK | -39.08% |
| 2014 Q1 | 4.46 Billion SEK | 2.45% |
| 2014 Q4 | 4.95 Billion SEK | 25.17% |
| 2014 Q3 | 3.96 Billion SEK | 6.82% |
| 2014 FY | 4.95 Billion SEK | 13.69% |
| 2014 Q2 | 3.7 Billion SEK | -17.01% |
| 2013 Q1 | 4.34 Billion SEK | 0.14% |
| 2013 Q3 | 4.34 Billion SEK | 0.91% |
| 2013 Q2 | 4.3 Billion SEK | -1.01% |
| 2013 Q4 | 4.36 Billion SEK | 0.46% |
| 2013 FY | 4.36 Billion SEK | 0.48% |
| 2012 FY | 4.34 Billion SEK | -1.74% |
| 2012 Q4 | 4.34 Billion SEK | 1.71% |
| 2012 Q3 | 4.26 Billion SEK | -2.38% |
| 2012 Q2 | 4.37 Billion SEK | -1.35% |
| 2012 Q1 | 4.43 Billion SEK | 0.32% |
| 2011 Q1 | 2.1 Billion SEK | 169.69% |
| 2011 Q4 | 4.41 Billion SEK | 68.14% |
| 2011 Q3 | 2.62 Billion SEK | 23.68% |
| 2011 FY | 4.41 Billion SEK | 464.83% |
| 2011 Q2 | 2.12 Billion SEK | 0.71% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 FY | 782 Million SEK | -16.54% |
| 2010 Q3 | 851 Million SEK | -4.81% |
| 2010 Q4 | 782 Million SEK | -8.11% |
| 2010 Q2 | 894 Million SEK | 0.0% |
| 2009 Q4 | 937 Million SEK | 0.0% |
| 2009 FY | 937 Million SEK | -37.86% |
| 2008 FY | 1.5 Billion SEK | 6.5% |
| 2007 FY | 1.41 Billion SEK | 68.57% |
| 2006 FY | 840 Million SEK | -19.92% |
| 2005 FY | 1.04 Billion SEK | 32.95% |
| 2004 FY | 789 Million SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| 2001 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AddLife AB (publ) | 2.53 Billion SEK | -89.327% |
| Biotage AB (publ) | 150 Million SEK | -3104.667% |
| Bonesupport Holding AB (publ) | 13.22 Million SEK | -36256.073% |
| Doxa AB (publ) | 3.6 Million SEK | -133427.778% |
| iZafe Group AB (publ) | 279 Thousand SEK | -1722839.068% |
| Ortivus AB (publ) | 3.57 Million SEK | -134399.161% |
| Ortivus AB (publ) | 3.57 Million SEK | -134399.161% |
| Q-linea AB (publ) | 12.9 Million SEK | -37149.128% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 2.02 Billion SEK | -136.915% |